EUVIMEDEUVIMED entdecken
Open Access

Preoperative Midazolam and Patient-Centered Outcomes of Older Patients

Ana Kowark, András P Keszei, Gerhard Schneider, Stefanie Pilge, Frederick Schneider, David P Obert, Marie-Therese Georgii, Markus Heim, Rolf Rossaint, Sebastian Ziemann, Julia van Waesberghe, Michael Czaplik und 17 weitere

JAMA Surgery · 2024

DOI: 10.1001/jamasurg.2023.6479 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Surgery, 2024. Verfasst von Ana Kowark und 28 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: Midazolam, Patient Satisfaction. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance The effect of oral midazolam premedication on patient satisfaction in older patients undergoing surgery is unclear, despite its widespread use.

Objective

To determine the differences in global perioperative satisfaction in patients with preoperative administration of oral midazolam compared with placebo. Design, Setting, and Participants This double-blind, parallel-group, placebo-controlled randomized clinical trial was conducted in 9 German hospitals between October 2017 and May 2019 (last follow-up, June 24, 2019). Eligible patients aged 65 to 80 years who were scheduled for elective inpatient surgery for at least 30 minutes under general anesthesia and with planned extubation were enrolled. Data were analyzed from November 2019 to December 2020.

Interventions

Patients were randomized to receive oral midazolam, 3.75 mg (n = 309), or placebo (n = 307) 30 to 45 minutes prior to anesthesia induction. Main Outcomes and Measures The primary outcome was global patient satisfaction evaluated using the self-reported Evaluation du Vécu de l’Anesthésie Generale (EVAN-G) questionnaire on the first postoperative day. Key secondary outcomes included sensitivity and subgroup analyses of the primary outcome, perioperative patient vital data, adverse events, serious complications, and cognitive and functional recovery up to 30 days postoperatively.

Results

Among 616 randomized patients, 607 were included in the primary analysis. Of these, 377 (62.1%) were male, and the mean (SD) age was 71.9 (4.4) years. The mean (SD) global index of patient satisfaction did not differ between the midazolam and placebo groups (69.5 [10.7] vs 69.6 [10.8], respectively; mean difference, −0.2; 95% CI, −1.9 to 1.6; P = .85). Sensitivity (per-protocol population, multiple imputation) and subgroup analyses (anxiety, frailty, sex, and previous surgical experience) did not alter the primary results. Secondary outcomes did not differ, except for a higher proportion of patients with hypertension (systolic blood pressure ≥160 mm Hg) at anesthesia induction in the placebo group. Conclusion and Relevance A single low dose of oral midazolam premedication did not alter the global perioperative patient satisfaction of older patients undergoing surgery or that of patients with anxiety. These results may be affected by the low dose of oral midazolam. Further trials—including a wider population with commonplace low-dose intravenous midazolam and plasma level measurements—are needed. Trial Registration ClinicalTrials.gov Identifier: NCT03052660

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MidazolamPatient SatisfactionAgedHumansMaleFemaleDouble-Blind MethodAnesthesia, GeneralPersonal SatisfactionPatient-Centered Care

Substanzen

Midazolam

Autor:innen und Institutionen

  • Department of Anaesthesiology and Intensive Care Medicine, University Hospital Bonn, Bonn, Germany.
  • Department of Anesthesiology, Medical Faculty University Hospital RWTH Aachen, Aachen, Germany.
  • Center for Translational & Clinical Research Aachen, Medical Faculty RWTH Aachen University, Aachen, Germany.
  • Department of Anesthesiology and Intensive Care, Technical University of Munich, School of Medicine, Munich, Germany.
  • Department for Anaesthesiology, Intensive Care, Emergency Medicine, Pain Therapy and Palliative Care, Kreiskliniken Reutlingen, Reutlingen, Germany.
  • Department of Anaesthesiology and Intensive Care, University Hospital Tübingen, Tübingen, Germany.

Zitieren

APA

Kowark, A., Keszei, A. P., Schneider, G., Pilge, S., Schneider, F., Obert, D. P., Georgii, M. T., Heim, M., Rossaint, R., Ziemann, S., van Waesberghe, J., Czaplik, M., Pühringer, F. K., Minarski, C., May, V., Malisi, T., Drexler, B., Ring, C. M., Engler, P., …, & I-PROMOTE Study Group (2024). Preoperative Midazolam and Patient-Centered Outcomes of Older Patients. JAMA Surgery. https://doi.org/10.1001/jamasurg.2023.6479

Vancouver

Kowark A, Keszei AP, Schneider G, Pilge S, Schneider F, Obert DP, et al. Preoperative Midazolam and Patient-Centered Outcomes of Older Patients. JAMA Surgery. 2024. doi:10.1001/jamasurg.2023.6479

BibTeX
@article{Kowark2024,
  author = {Kowark, Ana and Keszei, András P and Schneider, Gerhard and Pilge, Stefanie and Schneider, Frederick and Obert, David P and Georgii, Marie-Therese and Heim, Markus and Rossaint, Rolf and Ziemann, Sebastian and van Waesberghe, Julia and Czaplik, Michael and Pühringer, Friedrich K and Minarski, Christian and May, Verena and Malisi, Tobias and Drexler, Berthold and Ring, Carmen Maria and Engler, Phillip and Tilly, Roman and Bischoff, Petra and Frey, Ulrich and Wittmann, Maria and Soehle, Martin and Saller, Thomas and Kienbaum, Peter and Kretzschmar, Moritz and Coburn, Mark and I-PROMOTE Study Group, I-PROMOTE Study Group},
  title = {Preoperative Midazolam and Patient-Centered Outcomes of Older Patients},
  journal = {JAMA Surgery},
  year = {2024},
  doi = {10.1001/jamasurg.2023.6479}
}
Kostenlos starten →